Question 1

What is the catalog number for Mirzotamab (Anti-B7-H3 / CD276)?

Accepted Answer

The catalog number for Mirzotamab (Anti-B7-H3 / CD276) is C00673-1mg.

Question 2

What sizes are available for Mirzotamab (Anti-B7-H3 / CD276)?

Accepted Answer

Mirzotamab (Anti-B7-H3 / CD276) is available in the following size(s): 1 mg.

Question 3

Is Mirzotamab (Anti-B7-H3 / CD276) in stock?

Accepted Answer

Mirzotamab (Anti-B7-H3 / CD276) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is this product suitable for live cell imaging?

Accepted Answer

Suitability for live cell imaging depends on the specific reagent and conjugate used. Check the datasheet for imaging-specific validation, or contact us for guidance.

Question 5

Is this product covered by a money-back guarantee?

Accepted Answer

Yes, we guarantee a full refund or store credit if this product arrives damaged beyond usability, or has a genuine performance issue under proper usage and storage, provided you report it immediately with evidence. Claims after the expiration date or due to improper storage after receipt are excluded.

Question 6

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

Mirzotamab (Anti-B7-H3 / CD276)

Product Specifications

CAS Number

Target

Applications

Additionnal Information

Storage Conditions

Frequently Asked Questions

Explore Other Products

MUC18 / Mucin 18 / CD146 (OJ79c), CF405S conjugate, 0.1mg/mL

CD11a (Cris-3), CF488A conjugate, 0.1mg/mL

CD28 (204.12), CF770 conjugate, 0.1mg/mL

CD5 (Cris-1), CF594 conjugate, 0.1mg/mL

CD63 (MX-49.129.5), CF647 conjugate, 0.1mg/mL

Mammaglobin (SCGB2A2) (Breast Cancer Marker) (MGB1/2000), CF640R conjugate, 0.1mg/mL